PubPeer
The online Journal club
login
create account
Home
Publications
Merck's recall of rofecoxib--a strategic perspective
New England Journal of Medicine (2004) -
Comments
pubmed: 15548771 doi: 10.1056/nejmp048284 issn: 1533-4406 issn: 0028-4793
Felix Oberholzer-Gee, S. Noorein Inamdar
Go to article
Go to preprint
Massachusetts Medical Society
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})